TCEPX | VSTSX | TCEPX / VSTSX | |
Total Expense Ratio | 0.20 | 0.01 | 2,000% |
Annual Report Gross Expense Ratio | 0.20 | 0.01 | 2,000% |
Fund Existence | 16 years | 9 years | - |
Gain YTD | 7.059 | 6.427 | 110% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 53.5B | 1.82T | 3% |
Annual Yield % from dividends | 1.08 | 1.23 | 88% |
Returns for 1 year | 14.83 | 13.91 | 107% |
Returns for 3 years | 65.17 | 62.21 | 105% |
Returns for 5 years | 103.01 | 95.76 | 108% |
Returns for 10 years | 197.92 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BOCT | 45.76 | 0.27 | +0.59% |
Innovator U.S. Equity Buffer ETF™ Oct | |||
VWO | 50.02 | 0.22 | +0.44% |
Vanguard FTSE Emerging Markets ETF | |||
FXH | 103.17 | 0.20 | +0.19% |
First Trust Health Care AlphaDEX® ETF | |||
SPMV | 48.31 | N/A | N/A |
Invesco S&P 500 Minimum Variance ETF | |||
JHCB | 21.42 | -0.05 | -0.21% |
JHancock Corporate Bond ETF |